The DOI matches its Crossref record.
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care?
Open accessAbstract
BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been demonstrated to have an improved survival over systemic chemotherapy for patients with colorectal peritoneal carcinomatosis (CRPC) in a randomized controlled trial. Despite the increasing clinical evidence, controversies still exist regarding the standard treatment for these patients. METHODS: Between January 1997 and October 2007, 50 patients with isolated CRPC underwent CRS and HIPEC at the St. George Hospital, Sydney. All patients underwent preoperative chest, abdominal and pelvic computed tomography scans, and positron emission tomography. All clinicopathologic and treatment-related data were obtained prospectively and computed in univariate and multivariate analyses to determine their prognostic significance for overall survival. RESULTS: The mean age at the time of CRS was 55 (SD = 14) years. There were 19 (38%) male patients. The overall median survival was 29 months (range 1-102) with a 3-year survival rate of 39%. Three clinicopathologic factors were found to be significant for overall survival: tumor differentiation (P < 0.001), peritoneal cancer index (P = 0.021), and completeness of cytoreduction (P < 0.001). In the multivariate analysis of overall survival, 2 factors were identified to be independently associated with an improved survival: well-differentiated tumor (P = 0.045) and complete cytoreduction (P = 0.023). CONCLUSIONS: CRPC patients with low tumor volume, well/moderately differentiated tumors and complete cytoreduction may potentially benefit from the combined treatment. The combined treatment for patients with isolated colorectal peritoneal carcinomatosis should be considered to be the current standard of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- Sugarbaker, 1995, Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy., Ann Surg, 221, 124, 10.1097/00000658-199502000-00002 · doi:10.1097/00000658-199502000-00002
- Verwaal, 2003, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer., J Clin Oncol, 21, 3737, 10.1200/JCO.2003.04.187 · DOI · Paper page
- Glehen, 2004, Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study., J Clin Oncol, 22, 3284, 10.1200/JCO.2004.10.012 · DOI · Paper page
- Gomes da Silva, 2006, Analysis of 10 prognostic factors in 70 patients having complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer., Am J Coll Surg, 203, 878, 10.1016/j.jamcollsurg.2006.08.024 · doi:10.1016/j.jamcollsurg.2006.08.024
- Verwaal, 2005, Long-term survival of peritoneal carcinomatosis of colorectal origin., Ann Surg Oncol, 12, 65, 10.1007/s10434-004-1167-z · doi:10.1007/s10434-004-1167-z
- Glehen, 2004, Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin., Br J Surg, 91, 747, 10.1002/bjs.4473 · DOI
- Elias, 2006, Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery., Gastroenterol Clin Bio, 30, 1200, 10.1016/S0399-8320(06)73512-6 · DOI · Paper page
- Shen, 2004, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma., Ann Surg Oncol, 11, 178, 10.1245/ASO.2004.05.009 · doi:10.1245/aso.2004.05.009
- Pilati, 2003, Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma., Ann Surg Oncol, 10, 508, 10.1245/ASO.2003.08.004 · doi:10.1245/aso.2003.08.004
- Yan, 2006, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis., J Clin Oncol, 24, 4011, 10.1200/JCO.2006.07.1142 · DOI · Paper page
- Yan, 2006, Peritoneal carcinomatosis from colorectal carcinoma—standard of care., Ann Surg, 224, 623
- Jacquet, 1996, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis., Cancer Treat Res, 82, 359, 10.1007/978-1-4613-1247-5_23 · DOI · Paper page
- Sugarbaker, 1995, Peritonectomy procedures., Ann Surg, 221, 29, 10.1097/00000658-199501000-00004 · DOI · Paper page
- Verwaal, 2004, Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy., Br J Surg, 91, 739, 10.1002/bjs.4516 · doi:10.1002/bjs.4516
- Sugarbaker, 1996, Peritoneal carcinomatosis from adenocarcinoma of the colon., World J Surg, 20, 585, 10.1007/s002689900091 · doi:10.1007/s002689900091
- Pestieau, 2000, Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management., Dis Col Rect, 43, 1341, 10.1007/BF02236627 · DOI · Paper page
- Carmignani, 2004, The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer., Eur J Surg Oncol, 30, 391, 10.1016/j.ejso.2004.01.017 · doi:10.1016/j.ejso.2004.01.017
- Elias, 2001, Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy., Cancer, 92, 71, 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9 · DOI · Paper page
- Hadi, 2006, Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy., ANZ J Surg, 76, 156, 10.1111/j.1445-2197.2006.03579.x · doi:10.1111/j.1445-2197.2006.03579.x
- Shehata, 2006, Peritoneal carcinomatosis from colorectal cancer and small bowel cancer treated with peritonectomy., ANZ J Surg, 76, 467, 10.1111/j.1445-2197.2006.03749.x · doi:10.1111/j.1445-2197.2006.03749.x
- Yan, 2006, Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis—Non-mucinous tumor associated with an improved survival., Eur J Surg Oncol, 32, 1119, 10.1016/j.ejso.2006.06.007 · DOI
- Kecmanovic, 2005, Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy., Eur J Surg Oncol, 31, 147, 10.1016/j.ejso.2004.09.021 · doi:10.1016/j.ejso.2004.09.021
- Portilla, 1999, Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features., World J Surg, 23, 23, 10.1007/s002689900560 · doi:10.1007/s002689900560
- Gomes da Silva, 2005, Limited survival in the treatment of carcinomatosis from rectal cancer., Dis Col Rect, 48, 2258, 10.1007/s10350-005-0189-3 · doi:10.1007/s10350-005-0189-3
- Glehen, 2003, Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study., J Clin Oncol, 21, 799, 10.1200/JCO.2003.06.139 · doi:10.1200/jco.2003.06.139
- Loggie, 2000, Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin., Am Surg, 66, 561, 10.1177/000313480006600607 · doi:10.1177/000313480006600607
- Shen, 2003, Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis., Arch Surg, 138, 26, 10.1001/archsurg.138.1.26 · doi:10.1001/archsurg.138.1.26
- Culliford, 2001, Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer., Ann Surg Oncol, 8, 787, 10.1007/s10434-001-0787-9 · doi:10.1007/s10434-001-0787-9
- Elias, 2004, Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials., Ann Surg Oncol, 11, 518, 10.1245/ASO.2004.09.008 · DOI
- Esquivel, 2007, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the management of peritoneal surface malignancies of colonic origin: A Consensus Statement from the Peritoneal Surface Oncology Group., Ann Surg Oncol, 14, 128, 10.1245/s10434-006-9185-7 · doi:10.1245/s10434-006-9185-7
Cited by
Glehen, O., Gilly, F. N., Boutitie, F., Bereder, J. M., Quenet, F., Sideris, L., Mansvelt, B., Lorimier, G., Msika, S., & Elias, D. (2010) · Cancer · doi:10.1002/cncr.25356 · Cited by 524
Coccolini, F. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.6979 · Cited by 325
Thijs, I., Fresiello, L., Oosterlinck, W., Sinnaeve, P., & Rega, F. (2019) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9865 · Cited by 44
Metadata
- Authors
- Yan, T. D., & Morris, D. L.
- Venue
- Annals of Surgery
- Published
- 2008-11
- Volume
- 248
- Issue
- 5
- Pages
- 829-835
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2019028928
- Cited by
- 191
- References
- 0
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care? https://app.cochat.ai/papers/10.1097/sla.0b013e31818a15b5
- The paper
- Yan, T. D., & Morris, D. L. (2008). Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care? Annals of Surgery. https://doi.org/10.1097/sla.0b013e31818a15b5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.